Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2025

Jan 21, 2025

30016_dirs_2025-01-21_efb351f4-79d6-4700-bf1d-330d9ddcd389.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-12-31

Reporting Person: Erickson Michael G (Executive Vice President)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 19292.3617 Direct

Footnotes

F1: Reports an additional 8,588 shares of common stock held by the reporting person in a brokerage account as of January 1, 2024, the date on which he became an officer of IDEXX Laboratories, Inc.

F2: Includes a total of 47 shares purchased under the Issuer's Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 30, 2024 and December 31, 2024.